Pharmacogenomics education and research at the Department of Pharmacy, University of Patras, Greece. Patrinos GP, Katsila T. Pharmacogenomics. 2016 Nov;17(17):1865-1872. Posted on April 12, 2017May 14, 2019 by Wendy van Hemmen Continue reading →
Pharmacometabolomics Informs Viromics toward Precision Medicine. Balasopoulou A, Patrinos GP, Katsila T. Front Pharmacol. 2016 Oct 27;7:411. Posted on April 12, 2017May 14, 2019 by Wendy van Hemmen Continue reading →
Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available. Samwald M, Xu H, Blagec K, Empey PE, Malone DC, Ahmed SM, Ryan P, Hofer S, Boyce RD. PLoS One. 2016 Oct 20;11(10):e0164972. Posted on April 12, 2017May 14, 2019 by Wendy van Hemmen Continue reading →
The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity. Lauschke VM, Ingelman-Sundberg M. Int J Mol Sci. 2016 Oct 12;17(10). Posted on April 12, 2017May 14, 2019 by Wendy van Hemmen Continue reading →
Structure and function of multidrug and toxin extrusion proteins (MATEs) and their relevance to drug therapy and personalized medicine. Nies AT, Damme K, Kruck S, Schaeffeler E, Schwab M. Arch Toxicol. 2016 Jul;90(7):1555-84. Posted on April 12, 2017May 14, 2019 by Wendy van Hemmen Continue reading →
DNA Methylation of ADME Genes. Fisel P, Schaeffeler E, Schwab M. Clin Pharmacol Ther. 2016 May;99(5):512-27. Posted on April 12, 2017May 14, 2019 by Wendy van Hemmen Continue reading →
